Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Steroids for Nasal Ocular Response
NCT00473915Phase 4Completed
- Sponsor
- University of Chicago
- Start
- Apr 2007
- Primary completion
- Dec 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Fluticasone Furoate with Placebo (2 arms). Primary endpoint: Change in ocular symptoms. Started Apr 2007; status: completed.
02
Drugs
fluticasone
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00473915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473915.